PBM Accounting: Express Scripts Says Retail Rx Copays Are Not Revenue
Executive Summary
Express Scripts is urging the Securities & Exchange Commission to avoid setting PBM accounting standards that require companies to count patients' retail pharmacy copayments as revenue
You may also be interested in...
AdvancePCS copay revenue
AdvancePCS' revenue and cost of revenue would each increase "15-25%" for FY 2003 if SEC requires reporting of copays to clients as revenue, CEO David Halbert says. FY 2002 revenue without copays totaled $3.4 bil.; that number could grow as large as $4.3 bil. with addition of copay revenue. PBMs are preparing for a Securities & Exchange Commission decision on a uniform standard for copay accounting (1"The Pink Sheet" March 31, p. 26)...
AdvancePCS copay revenue
AdvancePCS' revenue and cost of revenue would each increase "15-25%" for FY 2003 if SEC requires reporting of copays to clients as revenue, CEO David Halbert says. FY 2002 revenue without copays totaled $3.4 bil.; that number could grow as large as $4.3 bil. with addition of copay revenue. PBMs are preparing for a Securities & Exchange Commission decision on a uniform standard for copay accounting (1"The Pink Sheet" March 31, p. 26)...
Express Scripts Mail-Order Rx Penetration Could Double In 5 Years, Firm Says
Express Scripts plans to push the percentage of prescriptions filled by mail-order over 35% within the next five years, Chief Financial Officer George Paz told the recent SG Cowen healthcare conference in Boston